Pediatric Cancer

PEDIATRIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Early Molecular Testing May Benefit Young Patients With Refractory Cancers

The study showed that tumor sequencing could identify actionable genetic alterations, which could then be used to assign patients to trials of molecularly targeted therapies.
Phthalates in Medications May Increase Risk of Childhood Cancers

Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
Cesarean Birth May Be Associated With Increased Childhood Cancer Risk

Cesarean was associated with increased risk of any cancer, hematopoietic cancers, and solid tumors.
Molecular Profiling Feasible for Recurrent Pediatric Cancer

Sixty-nine percent of patients had at least 1 genetic alteration leading to a targeted treatment suggestion.
Pediatric-Onset Inflammatory Bowel Disease May Up Cancer Risk

There is a greater than 2-fold increased risk of cancer among patients with pediatric-onset inflammatory bowel disease.

PEDIATRIC CANCER NEWS

An infant sleeping in a crib.

Real-World Outcomes of Tisagenlecleucel in Patients Younger Than 3 Years With Acute Lymphoblastic Leukemia

May 20, 2022

Researchers have identified actionable alterations in nearly 38% of patients with cancer, and almost 18% of patients were assigned to treatments based on their molecular profiling results.

Molecular Profiling Can Guide Treatment After Recurrence in Young Cancer Patients

May 11, 2022

Transplant Approach Produces “Promising” Long-Term Outcomes in Kids With Blood Cancers

May 4, 2022

Child in hospital bed

Outcomes of Pediatric Patients With Steroid-Refractory Acute Graft Vs Host Disease

May 3, 2022

Trials Investigating Bempegaldesleukin in Combination With Nivolumab Discontinued

April 19, 2022

Next post in Pediatric Cancer

Child in hospital bed

Phthalates in Medications May Increase Risk of Childhood Cancers